NasdaqCM - Delayed Quote USD

Cingulate Inc. (CING)

0.8801 +0.0148 (+1.71%)
At close: April 26 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
20,437.9820
17,502.2800
20,679.4890
7,084.2770
Operating Income
-20,437.9820
-17,502.2800
-20,679.4890
-7,084.2770
Net Non Operating Interest Income Expense
-768.2140
-174.5140
-30.5930
-100.2520
Pretax Income
-21,205.2770
-17,676.2320
-20,709.9910
-7,183.6150
Net Income Common Stockholders
-21,205.2770
-17,676.2320
-20,709.9910
-7,183.6150
Diluted NI Available to Com Stockholders
-21,205.2770
-17,676.2320
-20,709.9910
-7,183.6150
Basic EPS
-31.20
-31.20
-55.80
-12.70
Diluted EPS
-31.20
-31.20
-55.80
-12.70
Basic Average Shares
677.1650
566.5460
370.6780
565.4700
Diluted Average Shares
677.1650
566.5460
370.6780
565.4700
Total Operating Income as Reported
-20,437.0630
-17,501.7180
-20,679.3980
-7,083.3630
Rent Expense Supplemental
521.0000
478.0000
484.0000
371.0000
Total Expenses
20,437.9820
17,502.2800
20,679.4890
7,084.2770
Net Income from Continuing & Discontinued Operation
-21,205.2770
-17,676.2320
-20,709.9910
-7,183.6150
Normalized Income
-21,205.2770
-17,676.2320
-20,709.9910
-7,183.6150
Net Interest Income
-768.2140
-174.5140
-30.5930
-100.2520
EBIT
-20,437.9820
-17,502.2800
-20,679.4890
-7,084.2770
EBITDA
-19,937.6650
-17,108.2690
-19,971.1720
-6,418.2480
Reconciled Depreciation
500.3170
394.0110
708.3170
666.0290
Net Income from Continuing Operation Net Minority Interest
-21,205.2770
-17,676.2320
-20,709.9910
-7,183.6150
Normalized EBITDA
-19,937.6650
-17,108.2690
-19,971.1720
-6,418.2480
12/31/2020 - 12/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

FWBI First Wave BioPharma, Inc.
2.7400
+0.37%
 
NEXI NexImmune, Inc.
3.3700
-1.17%
 
PBLA Panbela Therapeutics, Inc.
0.4100
-6.82%
 
TENX Tenax Therapeutics, Inc.
3.4800
-0.85%
 
ADTX Aditxt, Inc.
2.3900
-5.53%
 
THAR Tharimmune, Inc.
0.3691
+2.50%
 
CDIO Cardio Diagnostics Holdings, Inc.
0.6900
-4.49%
 
SPRC SciSparc Ltd.
1.3200
+4.76%
 
TARA Protara Therapeutics, Inc.
2.9250
-4.10%
 
NRBO NeuroBo Pharmaceuticals, Inc.
3.1400
+2.61%